Login to Your Account

Other News To Note

Monday, January 24, 2011
Pfizer Inc., of New York, extended its tender offer for King Pharmaceuticals Inc., of Bristol, Tenn., to Jan. 28, 2011. Pfizer agreed to buy King in October for $14.25 per share, or about $3.6 billion.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription